image credit: Unsplash

Recce Pharmaceuticals Adds Biotech Veteran Alan W. Dunton M.D. to its Board of Directors

July 14, 2020


Recce Pharma Ltd (ASX: RCE) (Company), the Company developing new classes of synthetic anti-infectives, today announced the appointment of Alan W. Dunton, M.D., to its Board of Directors as an independent Non-Executive Director and as a member of the Company’s Audit & Risk and Remuneration & Nomination Committees.

“On behalf of all the team at Recce, we welcome Dr. Dunton to our Board of Directors,” stated Dr. John Prendergast, Recce Pharmaceuticals Non-Executive Chairman.

Read More on BioSpace